Add Yahoo as a preferred source to see more of our stories on Google. CANARY ISLANDS, Spain — The business model underpinning kids and family animation is under growing strain, as a post-streaming ...

Maddy Buxton, Culture & Trends manager at YouTube, discusses how creators and digital animation on the platform are global, fan-driven, popular among young adults, and driving innovation and ...

C3G and IC-MPGN can be difficult to diagnose because they are so rare and their symptoms are vague and nonspecific. A kidney biopsy is considered the gold standard and usually needed to confirm the ...

The new pathway aligns with health leaders' stated goal of reducing red tape for cell and gene therapies, but contrasts with the surprising recent rejections of ...

Health officials including FDA Commissioner Marty Makary, M.D., have openly voiced support for the development of novel cell and gene therapies. (Brendan Smialowski/AFP via Getty Images) In a highly ...

NEW YORK, Nov 12 (Reuters) - The U.S. Food and Drug Administration can approve new personalized treatments for rare and deadly genetic diseases based on data from a handful of patients, two of the ...

SAN FRANCISCO -- The investigational complement-targeting agent claseprubart was safe and led to significant improvements in generalized myasthenia gravis (MG), the phase II MaGic trial showed. The ...

Complement 3 glomerulopathy (C3G) is a rare kidney disease that affects your body’s innate immune system (complement system). Complement 3 glomerulopathy (C3G) is a kidney disease that’s caused by ...

The animation industry has always been labor-intensive, blending artistry, innovation, and technology to bring stories to life. Now, a new technological shift, generative AI (genAI), is sparking ...

Health tech company Doximity bought Pathway Medical to bulk up its healthcare artificial intelligence capabilities as it looks to offer more free AI tools to doctors. The transaction closed July 29 ...